Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/194018
Anti-Amyloid Drug Screening Methods Using Bacterial Inclusion Bodies
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Amyloid aggregation is linked to a number of human disorders that range from non-neurological illnesses such as type 2 diabetes to neurodegenerative diseases such as Alzheimer's and Parkinson's diseases. The formation of insoluble protein aggregates with amyloid conformation inside bacteria, namely, in bacterial inclusion bodies, offers the possibility to use bacteria as simple models to study amyloid aggregation processes and potential effects of both anti-amyloid drugs and/or pro-aggregative compounds. This chapter describes fast, simple, inexpensive, highly reproducible, and tunable in vitro and in cellulo methods that use bacterial inclusion bodies as preliminary screening tools for anti-amyloid drugs. Keywords: Amyloid aggregation; Bacterial inclusion body; Conformational disease; Drug screening.
Matèries
Matèries (anglès)
Citació
Citació
CABALLERO HERNÁNDEZ, Ana belén, GÁMEZ ENAMORADO, Patrick, SABATÉ LAGUNAS, Raimon, ESPARGARÓ COLOMÉ, Alba. Anti-Amyloid Drug Screening Methods Using Bacterial Inclusion Bodies. _Methods in Molecular Biology_. 2022. Vol. 2538, núm. 165-188. [consulta: 24 de gener de 2026]. ISSN: 1940-6029. [Disponible a: https://hdl.handle.net/2445/194018]